StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 28 Sep 2022 07:12:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Confirms+Focus+on+Treatment+of+Post+COVID-19+Conditions/20634633.html Wed, 28 Sep 2022 07:12:00 -0400 A.06822034 A.14320728 O.02537940 O.20026344 O.20248598 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html for the full story. http://www.streetinsider.com/Globe+Newswire/Resverlogix+Publishes+New+Data+Highlighting+Apabetalone%E2%80%99s+Benefit+in+Non-alcoholic+Fatty+Liver+Disease/20492401.html Mon, 22 Aug 2022 07:12:00 -0400 A.06822034 A.19724915 O.00042070 O.02537940 O.20026344 RVX Resverlogix Announces Appointment of New Chief Scientific Officer http://www.streetinsider.com/Press+Releases/Resverlogix+Announces+Appointment+of+New+Chief+Scientific+Officer/20469056.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Resverlogix+Announces+Appointment+of+New+Chief+Scientific+Officer/20469056.html for the full story. http://www.streetinsider.com/Press+Releases/Resverlogix+Announces+Appointment+of+New+Chief+Scientific+Officer/20469056.html Mon, 15 Aug 2022 18:00:00 -0400 O.02537940 RVX